[
    {
        "Id": "25b0a2a5-4a02-46e1-8c0c-885ba40b22fd",
        "Name": "Acute haemorrhagic fever syndrome",
        "ReadableId": 1,
        "Threshold": null,
        "CaseDefinition": "A suspected case with laboratory confirmation or epidemiologic link to confirmed cases or outbreak. ",
        "KeyMessage": "",
        "KeyAction": "During an outbreak, case definitions may be changed to correspond to the local event."
    },
    {
        "Id": "b5eec382-8c4f-46cb-bf68-3fcd9b3cbf53",
        "Name": "Acute viral hepatitis",
        "ReadableId": 2,
        "Threshold": null,
        "CaseDefinition": "A suspected case that is laboratory confirmed",
        "KeyMessage": "",
        "KeyAction": "Infected children are often asymptomatic."
    },
    {
        "Id": "eea0d4e2-2a8d-49d2-bfc9-f5150679bd04",
        "Name": "Adverse events following immunization (AEFI)",
        "ReadableId": 3,
        "Threshold": null,
        "CaseDefinition": "",
        "KeyMessage": "",
        "KeyAction": ""
    },
    {
        "Id": "7e738756-4188-4461-9d31-d6ccd4521215",
        "Name": "Anthrax",
        "ReadableId": 4,
        "Threshold": null,
        "CaseDefinition": "Clinically compatible case of cutaneous, inhalational or gastrointestinal illness that is laboratory-confirmed by: a) isolation of B. anthracis from an affected tissue or site; or b) Other laboratory evidence of B. anthracis infection based on at least two supportive laboratory tests.",
        "KeyMessage": "",
        "KeyAction": "It may not be possible to demonstrate B. anthracis in clinical specimens if the patient has been treated with antimicrobial agents."
    },
    {
        "Id": "dc6e75aa-2b34-43e3-abd3-6ee2f65c514b",
        "Name": "Buruli ulcer (Mycobacterium ulcerans disease)",
        "ReadableId": 5,
        "Threshold": null,
        "CaseDefinition": "A suspected case confirmed by at least one laboratory test (ZN for AFB, PCR, culture or histology)",
        "KeyMessage": "",
        "KeyAction": ""
    },
    {
        "Id": "d3a14cc4-9acd-42d1-8c35-5674529edad8",
        "Name": "Chikungunya ",
        "ReadableId": 6,
        "Threshold": null,
        "CaseDefinition": "A suspected case with laboratory confirmation. ",
        "KeyMessage": "",
        "KeyAction": ""
    },
    {
        "Id": "8f4dbcc2-bb99-4a21-beca-23ec7c65c900",
        "Name": "Cholera ",
        "ReadableId": 7,
        "Threshold": 1,
        "CaseDefinition": "A suspected case in which Vibrio cholerae O1 or O139 has been isolated in the stool.",
        "KeyMessage": "",
        "KeyAction": ""
    },
    {
        "Id": "91144cde-2dc6-491f-b4a4-d8c0c4938516",
        "Name": "Dengue Fever",
        "ReadableId": 8,
        "Threshold": null,
        "CaseDefinition": "A suspected case with laboratory confirmation (positive IgM antibody, rise in IgG antibody titres, positive PCR or viral isolation). ",
        "KeyMessage": "",
        "KeyAction": ""
    },
    {
        "Id": "7cfc7451-27bb-4299-b528-53d03f927bae",
        "Name": "Dengue Haemorrhagic Fever",
        "ReadableId": 9,
        "Threshold": null,
        "CaseDefinition": "One or more of the following: a) positive tourniquet test; b) petechieae, ecchymoses or purpura; c) bleeding: mucosa, gastrointestinal tract, injection sites or other; d) haematemesis or melaena; e) thrombocytopenia (100,000 cells or less per mm3) AND evidence of plasma leakage due to increased vascular permeability, manifested by one or more of the following: a) 20% rise in average haematocrit for age and sex; b) 20% drop in haematocrit following volume replacement therapy compared to baseline; c) signs of plasma leakage (pleural effusion, ascites, hypo-proteinaemia).",
        "KeyMessage": "",
        "KeyAction": ""
    },
    {
        "Id": "4eb00205-8349-4d41-83da-3eef7cef1e21",
        "Name": "Dengue Shock Syndrome",
        "ReadableId": 10,
        "Threshold": null,
        "CaseDefinition": "All Dengue Haemorrhagic Fever symptoms AND a) evidence of circulatory failure manifested by rapid and weak pulse; b) narrow pulse pressure (≤ 20 mm Hg); OR a) hypotension for age; b) cold, clammy skin; c) altered mental status.",
        "KeyMessage": "",
        "KeyAction": ""
    },
    {
        "Id": "4d4d5539-5ed2-4c0c-925e-449b524f72b5",
        "Name": "Diabetes",
        "ReadableId": 11,
        "Threshold": null,
        "CaseDefinition": "Any person with a fasting venous plasma glucose measurement of ≥ 7 mmol/L (126 mg/dl) or capillary glucose ≥ 6.1 mmol/L (110 mg/dl) OR any person with a non-fasting venous plasma glucose measurement of ≥ 11.1mmol/L (200 mg/dl) or capillary glucose ≥ 11,1 nnik>k (200 mg/dl)",
        "KeyMessage": "",
        "KeyAction": "Report only the first lab-confirmed diagnosis of the patient."
    },
    {
        "Id": "2407d31b-f6d3-4ee4-bb93-f8a751e00705",
        "Name": "Diarrhoea with blood (dysentery/Shigella) ",
        "ReadableId": 12,
        "Threshold": 1,
        "CaseDefinition": "Suspected case with stool culture positive for Shigella dysenteriae type 1.",
        "KeyMessage": "",
        "KeyAction": ""
    },
    {
        "Id": "e1fe0ef1-28df-405c-b862-938f9f4edfa0",
        "Name": "Dracunculiasis",
        "ReadableId": 13,
        "Threshold": null,
        "CaseDefinition": "At the last phase of the programme, confirmation of last cases by knowledgeable health staff is required. Follow national guidelines for definition of confirmed case.",
        "KeyMessage": "",
        "KeyAction": ""
    },
    {
        "Id": "842dbf81-7a18-472b-a07b-5d28107c0509",
        "Name": "Ebola or Marburg viral hemorrhagic Fevers",
        "ReadableId": 14,
        "Threshold": null,
        "CaseDefinition": "A suspected case with laboratory confirmation (positive IgM antibody, positive PCR or viral isolation), or epidemiologic link to confirmed cases or outbreak.",
        "KeyMessage": "",
        "KeyAction": "During an outbreak, these case definitions may be changed to correspond to the local event."
    },
    {
        "Id": "8abbe4d6-9d1f-40a2-9450-39ce0404efda",
        "Name": "Foodborne Illnesses",
        "ReadableId": 15,
        "Threshold": null,
        "CaseDefinition": "A laboratory confirmed case of a specific agent with a link to a common food or drink source.",
        "KeyMessage": "",
        "KeyAction": "A foodborne illness is defined according to the specific agent causing the disease (for example, cholera, hepatitis A, salmonellosis, shigellosis)."
    },
    {
        "Id": "8d926129-8886-47b4-ad26-b8a80f04fa35",
        "Name": "Human influenza (caused by a new subtype) ",
        "ReadableId": 16,
        "Threshold": 1,
        "CaseDefinition": "A person meeting the criteria for a suspected case AND positive laboratory results from a laboratory whose H5N1 test results are accepted by WHO as confirmatory.",
        "KeyMessage": "",
        "KeyAction": ""
    },
    {
        "Id": "a5502157-2057-485d-8b61-58510640d0da",
        "Name": "Pandemic (H1N1) 2009 virus infection",
        "ReadableId": 17,
        "Threshold": null,
        "CaseDefinition": "An individual with a laboratory-confirmed pandemic (H1N1) 2009 virus infection by one or more of the following tests: a) PCR; b) viral culture; c) 4-fold rise in pandemic (H1N1) 2009 virus-specific neutralizing antibodies.",
        "KeyMessage": "",
        "KeyAction": ""
    },
    {
        "Id": "8fd0639a-053c-490d-ab1a-9d005ddf01eb",
        "Name": "Hypertension",
        "ReadableId": 18,
        "Threshold": null,
        "CaseDefinition": "Any individual presenting on at least two occasions with a resting blood pressure measurement (based on the average of 3 readings) at or above 140 mm Hg for systolic pressure, or greater than or equal to 90 mm Hg for diastolic pressure.",
        "KeyMessage": "",
        "KeyAction": ""
    },
    {
        "Id": "29c8e3ef-bb47-4b4f-8303-b5aaa053c8cf",
        "Name": "Influenza-like Illness (ILI)",
        "ReadableId": 19,
        "Threshold": null,
        "CaseDefinition": "Meets the clinical case definition and is laboratory confirmed (laboratory results must be positive for influenza virus).",
        "KeyMessage": "",
        "KeyAction": ""
    },
    {
        "Id": "95b405db-9db2-4cd3-8270-cb8a9a10d1b9",
        "Name": "Crimean-Congo Haemorrhagic Fever (CCHF)",
        "ReadableId": 20,
        "Threshold": null,
        "CaseDefinition": "A suspected case with laboratory confirmation (positive IgM antibody, PCR, viral isolation or IgG seroconversion by ELISA or IFA) OR epidemiologic link to confirmed cases or outbreak.",
        "KeyMessage": "",
        "KeyAction": ""
    },
    {
        "Id": "043a4cae-1e9d-4a1c-849b-be1e56deac6e",
        "Name": "Lassa Fever",
        "ReadableId": 21,
        "Threshold": null,
        "CaseDefinition": "A suspected case that is laboratory confirmed (positive IgM antibody, PCR or virus isolation) or epidemiologically linked to a laboratory confirmed case.",
        "KeyMessage": "",
        "KeyAction": ""
    },
    {
        "Id": "fb6454da-36cf-4cce-8862-ef691cf7ddf5",
        "Name": "Leprosy",
        "ReadableId": 22,
        "Threshold": null,
        "CaseDefinition": "A person showing at least two cardinal signs of leprosy and who has not completed a full course of treatment with Multi Drug Therapy (MDT).",
        "KeyMessage": "",
        "KeyAction": ""
    },
    {
        "Id": "61c6d78e-0def-4924-a782-2d64c37818ae",
        "Name": "Lymphatic Filariasis",
        "ReadableId": 23,
        "Threshold": null,
        "CaseDefinition": "A person with positive laboratory diagnosis of microfilaremia in blood smear, filarial antigenaemia or positive ultrasound test.",
        "KeyMessage": "",
        "KeyAction": ""
    },
    {
        "Id": "f4a6d677-2463-4130-b3b2-83a439842a29",
        "Name": "Malaria (uncomplicated)",
        "ReadableId": 24,
        "Threshold": null,
        "CaseDefinition": "Any person with fever or history of fever within 24 hours; AND with laboratory confirmation of diagnosis by malaria blood film or other diagnostic test for malaria parasites.",
        "KeyMessage": "",
        "KeyAction": ""
    },
    {
        "Id": "064a23e5-1064-4d28-bdab-5a0702c87f25",
        "Name": "Malaria (severe)",
        "ReadableId": 25,
        "Threshold": null,
        "CaseDefinition": "Any patient hospitalized with P. falciparumasexual parasitaemia as confirmed by laboratory tests with accompanying symptoms and signs of severe disease (vital organ dysfunction) diagnosed through laboratory.",
        "KeyMessage": "",
        "KeyAction": ""
    },
    {
        "Id": "a37105a1-4f9d-4448-ad25-75831f5b0184",
        "Name": "Malnutrition (newborns)",
        "ReadableId": 26,
        "Threshold": null,
        "CaseDefinition": "Any new born with a birth weight less than 2500 grams (or 5.5 lbs).",
        "KeyMessage": "",
        "KeyAction": ""
    },
    {
        "Id": "abfcd715-e8e4-4f4c-aaa8-dc4af260fbab",
        "Name": "Malnutrition (children)",
        "ReadableId": 27,
        "Threshold": null,
        "CaseDefinition": "a) Children under five who are underweight (indicator: weight for age<-2 ZScore); b) Children 6 to 59 months with MUAC<11.5 cm (high risk of mortality); c) Bilateral pitting oedema",
        "KeyMessage": "",
        "KeyAction": ""
    },
    {
        "Id": "64c58e5f-3ad7-4f70-8074-4d9c8909f9a0",
        "Name": "Malnutrition (pregnant women)",
        "ReadableId": 28,
        "Threshold": null,
        "CaseDefinition": "Pregnant women given birth to low birth weight babies (birth weight < 2.5 Kg).",
        "KeyMessage": "",
        "KeyAction": "Poor nutritional and health status of the women, can predict which population groups may benefit from improved antenatal care of women and neonatal care for infants."
    },
    {
        "Id": "017fa3d3-3f69-4574-b950-b8d248d72e3d",
        "Name": "Maternal Deaths",
        "ReadableId": 29,
        "Threshold": null,
        "CaseDefinition": "The death of a woman while pregnant or within 42 days of the delivery or termination of pregnancy, irrespective of the duration and site of the pregnancy, from any cause related to or aggravated by the pregnancy or its management but not from accidental or incidental causes.",
        "KeyMessage": "",
        "KeyAction": ""
    },
    {
        "Id": "5b59d35c-942a-444d-a808-00c996b91441",
        "Name": "Measles",
        "ReadableId": 30,
        "Threshold": 1,
        "CaseDefinition": "A suspected case with laboratory confirmation (positive IgM antibody) or epidemiological link to confirmed cases in an outbreak.",
        "KeyMessage": "",
        "KeyAction": ""
    },
    {
        "Id": "0bbca1dd-781a-4d5f-b5ef-2133ec4fb357",
        "Name": "Meningococcal Meningitis",
        "ReadableId": 31,
        "Threshold": null,
        "CaseDefinition": "A suspected case confirmed by isolation ofN. meningitidisfrom CSF or blood.",
        "KeyMessage": "",
        "KeyAction": ""
    },
    {
        "Id": "e8c49ebf-9b95-4d9f-991e-b8312c9c9f75",
        "Name": "Neonatal tetanus",
        "ReadableId": 32,
        "Threshold": null,
        "CaseDefinition": "No laboratory confirmation recommended.",
        "KeyMessage": "",
        "KeyAction": ""
    },
    {
        "Id": "63890cbf-3636-4939-8063-e5d3c206c3d9",
        "Name": "New AIDS Cases",
        "ReadableId": 33,
        "Threshold": null,
        "CaseDefinition": "A positive ELISA for confirming HIV and a rapid test for confirming the positive results are sufficient for an epidemiologic case definition for HIV Infection.",
        "KeyMessage": "",
        "KeyAction": "WHO/AFRO recommends that countries use either Bangui or Abidjan HIV/AIDSR case definitions."
    },
    {
        "Id": "a64a1773-fc0b-4e75-981d-13a8fd29d588",
        "Name": "Noma",
        "ReadableId": 34,
        "Threshold": null,
        "CaseDefinition": "Any person with a gangrenous disease which starts as gingival ulceration and spreads rapidly through the tissues of the mouth and face, destroying the soft and hard tissues.",
        "KeyMessage": "",
        "KeyAction": ""
    },
    {
        "Id": "83f80b7b-ffa3-49f3-ac0a-a0c1b80dc01d",
        "Name": "Onchocerciasis",
        "ReadableId": 35,
        "Threshold": null,
        "CaseDefinition": "A suspected case that is laboratory confirmed by presence of one or more of the following: a) microfilariae in skin snips; b) adult worms in excised nodules; c) typical ocular manifestations (such as slit-lamp observations of microfilariae in the cornea, the anterior chamber, or the vitreous body).",
        "KeyMessage": "",
        "KeyAction": ""
    },
    {
        "Id": "a10f1ff9-cdc8-40c4-a2e9-e3ddcae3b088",
        "Name": "Plague",
        "ReadableId": 36,
        "Threshold": null,
        "CaseDefinition": "Suspected case confirmed by isolation of Yersinia pestisfrom blood or aspiration of buboes, OR epidemiologic link to confirmed cases or outbreak.",
        "KeyMessage": "",
        "KeyAction": ""
    },
    {
        "Id": "b0c8371c-29f6-4ba9-ab87-0037f6a28743",
        "Name": "Poliomyelitis (Acute flaccid paralysis)",
        "ReadableId": 37,
        "Threshold": null,
        "CaseDefinition": "A suspected case with virus isolation in stool.",
        "KeyMessage": "",
        "KeyAction": ""
    },
    {
        "Id": "0b0fa4c5-5a6a-40e5-8342-e6963fb37672",
        "Name": "Rabies",
        "ReadableId": 38,
        "Threshold": null,
        "CaseDefinition": "A suspected case that is laboratory confirmed.",
        "KeyMessage": "",
        "KeyAction": ""
    },
    {
        "Id": "68e5a4c4-11ac-47dd-b802-a96c2a5343dc",
        "Name": "Rift Valley Fever (RVF)",
        "ReadableId": 39,
        "Threshold": null,
        "CaseDefinition": "Any patient who, after clinical screening, is positive for anti- RVF IgM ELISA antibodies (typically appear from fourth to sixth day after onset of symptoms) or tests positive on Reverse Transcriptase Polymerase Chain Reaction (RT-PCR).",
        "KeyMessage": "",
        "KeyAction": ""
    },
    {
        "Id": "7f6247f2-bd3f-476c-a0e4-d2d59019ef88",
        "Name": "Severe Acute Respiratory Infections (SARIs) (persons ≥ 5 years old)",
        "ReadableId": 40,
        "Threshold": null,
        "CaseDefinition": "",
        "KeyMessage": "",
        "KeyAction": ""
    },
    {
        "Id": "c35ec35c-1679-4efc-a3b6-19f55cb79762",
        "Name": "Severe Acute Respiratory Syndrome (SARS)",
        "ReadableId": 41,
        "Threshold": 1,
        "CaseDefinition": "An individual who tests positive for SARS-CoV infection by the WHO recommended testing procedures.",
        "KeyMessage": "",
        "KeyAction": ""
    },
    {
        "Id": "d43e7111-28ae-418f-b73f-dbd2166e499d",
        "Name": "Pneumonia (Children under 5)",
        "ReadableId": 42,
        "Threshold": null,
        "CaseDefinition": "A child presenting with cough or difficult breathing and: a) 50 or more breaths per minute for infant age 2 months up to 1 year; b) 40 or more breaths per minute for young child 1 year up to 5 years.",
        "KeyMessage": "",
        "KeyAction": "A young infant age 0 up to 2 months with cough and fast breathing is classified in IMCI as “serious bacterial infection” and is referred for further evaluation."
    },
    {
        "Id": "addf7f95-f101-4dfa-86af-0bd9c083144b",
        "Name": "Severe Pneumonia (Children under 5)",
        "ReadableId": 43,
        "Threshold": null,
        "CaseDefinition": "Radiographic or laboratory confirmation of pneumonia may not be feasible in most districts.",
        "KeyMessage": "",
        "KeyAction": ""
    },
    {
        "Id": "f686692c-bb6c-403d-8dc8-b56e87ad131c",
        "Name": "Genital ulcer syndrome (non-vesicular)",
        "ReadableId": 44,
        "Threshold": null,
        "CaseDefinition": "Any suspected case confirmed by a laboratory method.",
        "KeyMessage": "",
        "KeyAction": "Sexually Transmitted Infection (STI)"
    },
    {
        "Id": "dd38968c-7e15-4898-8826-f46123f60a07",
        "Name": "Urethral discharge syndrome",
        "ReadableId": 45,
        "Threshold": null,
        "CaseDefinition": "A suspected case confirmed by a laboratory method (for example Gram stain showing intracellular Gram- negative diplococci).",
        "KeyMessage": "",
        "KeyAction": "Sexually Transmitted Infection (STI)"
    },
    {
        "Id": "011948e5-0d96-46ae-aff3-2090d96ab1c7",
        "Name": "Smallpox (Variola)",
        "ReadableId": 46,
        "Threshold": 1,
        "CaseDefinition": "A clinically compatible case that is laboratory confirmed.",
        "KeyMessage": "",
        "KeyAction": ""
    },
    {
        "Id": "7a23de7c-3e43-4bdb-99d8-3a2fb15fd7ce",
        "Name": "Trachoma",
        "ReadableId": 47,
        "Threshold": null,
        "CaseDefinition": "Any patient with red sticky eyes who complains of pain and itchiness of the eyes where examination of the eyes confirms one of the stages of Trachoma infection according to the WHO Simplified Trachoma Grading System.",
        "KeyMessage": "",
        "KeyAction": ""
    },
    {
        "Id": "21d4d74b-611a-49c5-9d03-086604bba368",
        "Name": "Trypanosomiasis",
        "ReadableId": 48,
        "Threshold": null,
        "CaseDefinition": "A suspected case confirmed by card agglutination trypanosomal test (CATT) or by isolation of trypanosomes in blood lymph nodes or cerebrospinal fluid.",
        "KeyMessage": "",
        "KeyAction": ""
    },
    {
        "Id": "223c7068-45c7-4eee-98d7-10ea3c80e0c4",
        "Name": "Tuberculosis",
        "ReadableId": 49,
        "Threshold": null,
        "CaseDefinition": "Smear-positive pulmonary TB: a) a suspected patient with at least 2 sputum specimens positive for acid-fast bacilli (AFB); b) one sputum specimen positive for AFB by microscopy and radiographic abnormalities consistent with active PTB as determined by the treating medical officer; c) one positive sputum smear by microscopy and one sputum specimen positive on culture for AFB. Smear negative PTB: a patient who fulfils all the following criteria: a) two sets taken at least 2 weeks apart of at least two sputum specimens negative for AFB on microscopy, radiographic abnormalities consistent with PTB and a lack of clinical response despite one week of a broad spectrum antibiotic, a decision by a physician to treat with a full course of anti-TB chemotherapy; b) a patient who fulfils all the following criteria: severely ill, at least two sputum specimens negative for AFB by microscopy, radiographic abnormalities consistent with extensive pulmonary TB (interstitial and miliary), a decision by a physician to treat with a full course of anti-TB chemotherapy; c) a patient whose initial sputum smears were negative, who had sputum sent for culture initially, and whose subsequent sputum culture result is positive.",
        "KeyMessage": "",
        "KeyAction": ""
    },
    {
        "Id": "6a09a486-2613-4299-9555-c913f0d4feb2",
        "Name": "Typhoid Fever",
        "ReadableId": 50,
        "Threshold": null,
        "CaseDefinition": "Suspected case confirmed by isolation of Salmonella typhifrom blood, bone marrow, bowel fluid or stool.",
        "KeyMessage": "",
        "KeyAction": ""
    },
    {
        "Id": "7ea09d46-78af-442a-879b-d32646b436c9",
        "Name": "West Nile Fever",
        "ReadableId": 51,
        "Threshold": null,
        "CaseDefinition": "Confirmation of West Nile Fever is through laboratory diagnostics to identify WNV-specific IgM.",
        "KeyMessage": "",
        "KeyAction": ""
    },
    {
        "Id": "66e37f61-b2a9-4a3d-8d52-fb208f305b11",
        "Name": "Yellow fever",
        "ReadableId": 52,
        "Threshold": null,
        "CaseDefinition": "A probable case AND one of the following: a) Detection of YF-specific* IgM; b) Detection of four-fold increase in YF IgM and/or IgG antibody titres between acute and convalescent serum samples; c) Detection of YFV-specific* neutralizing antibodies; OR one of the following: a) Detection of YF virus genome in blood or other organs by PCR; b) Detection of yellow fever antigen in blood, liver or other organs by immunoassays; OR Isolation of the yellow fever virus.",
        "KeyMessage": "",
        "KeyAction": "*YF-specific means that antibody tests (such as IgM or neutralizing antibody) for other prevalent flavivirus are negative. This testing should include at least IgM for Dengue and West Nile and may include other flavivirus depending on local epidemiology."
    }
]